我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
0
0 进行中
药物批准
8
批准总数
监管机构
1
监管机构数
成立时间
N/A
暂无试验阶段数据
暂无试验数据
FDA
Food and Drug Administration
- Cencora announced a $1.1 billion acquisition of EyeSouth Partners' retina business to strengthen its specialty medical services division. - The deal will integrate EyeSouth's retina-focused physicians into Cencora's existing eye-care arm, Retina Consultants of America. - This marks the third major retina-focused eye-care network acquisition by a distributor, following similar moves by competitors in the consolidating market. - The transaction is expected to be slightly accretive to adjusted earnings per share in the first twelve months after closing.
